Levitra ( DrugBank: - )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1
86	肺動脈性肺高血圧症	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-003761-33-ES (EUCTR)	17/02/2005	25/01/2006	Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDE	Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDE	Erectile Dysfunction	Trade Name: Levitra Product Name: Vardenafil (hidrocloride) INN or Proposed INN: VARDENAFILO HIDROCLORURO Trade Name: Levitra Product Name: Vardenafil (hidrocloride) INN or Proposed INN: VARDENAFILO HIDROCLORURO Trade Name: Levitra Product Name: Vardenafil (hidrocloride) INN or Proposed INN: VARDENAFILO HIDROCLORURO	Unidad de Neuroinmunología	NULL	Not Recruiting			Female: Male: yes	28	Phase 4	Spain

86. 肺動脈性肺高血圧症

---

臨床試験数 : 1,181 /  薬物数 : 701 - (DrugBank : 126) / 標的遺伝子数 : 105 - 標的パスウェイ数 : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01649739 (ClinicalTrials.gov)	September 2012	22/7/2012	Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost		Pulmonary Arterial Hypertension	Drug: Levitra	Rabin Medical Center	NULL	Not yet recruiting	18 Years	70 Years	Both	20	Phase 4	Israel